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While splicing differences between tissues, sexes and species are well documented, little is known
about the extent and the nature of splicing changes that take place during human or mammalian
development and aging. Here, using high-throughput transcriptome sequencing, we have
characterized splicing changes that take place during whole human lifespan in two brain regions:
prefrontal cortex and cerebellum. Identified changeswere confirmed using independent human and
rhesus macaque RNA-seq data sets, exon arrays and PCR, and were detected at the protein level
using mass spectrometry. Splicing changes across lifespan were abundant in both of the brain
regions studied, affecting more than a third of the genes expressed in the human brain.
Approximately 15% of these changes differed between the two brain regions. Across lifespan,
splicing changes followed discrete patterns that could be linked to neural functions, and associated
with the expression profiles of the corresponding splicing factors. More than 60% of all splicing
changes represented a single splicing pattern reflecting preferential inclusion of gene segments
potentially targeting transcripts for nonsense-mediated decay in infants and elderly.
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Introduction
Alternative splicing (AS) is a process that allows a single gene to
produce multiple transcripts and, consequently, multiple pro-
teins, by utilizing different splice sites in pre-mRNA (Maniatis,
1991). Splicing is mediated by the spliceosome, a dynamic
complex containing both RNA and proteins, which catalyzes
intron excision and joining of exons. This process may be
affected by numerous splicing factors (SFs), proteins that bind to
specific binding motifs (SFBMs) on pre-mRNA and affect
spliceosome preferences for splicing sites (Black, 2003).
Transcriptome-wide splicing studies conducted using micro-
arrays, EST data analysis and, more recently, high-throughput
sequencing have revealed extensive splicing differences among
tissues, sexes, and species (Calarco et al, 2007; Blekhman et al,
2010). Particularly, AS is widespread in higher eukaryotes,
affecting up to 95% of human multi-exon genes (Johnson et al,
2003; Pan et al, 2008; Wang et al, 2008; Takeda et al, 2010).
Transcriptome-wide studies of AS conducted to date have
mainly focused on splicing differences among tissues, rather
than splicing changes with age. On the individual gene level,
changes in transcript splicing have been shown to have
important roles in many human developmental processes,
including neuronal cell migration (Blencowe, 2006), synapse
formation (Ule et al, 2005), and establishing neurotransmitter
receptor specificity (Dredge et al, 2001). In human aging, AS is
associated with age-related disorders, such as Alzheimer’s
disease (Buee et al, 2000), amyotrophic lateral sclerosis
(Dredge et al, 2001), and cancer (Venables et al, 2009).
Accordingly, the AS changes found in human aging and
neurodegeneration were shown to overlap (Tollervey et al,
2011). Further, altered splicing of lamin A/C (LMNA) has been
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linked to a human premature aging phenotype (De Sandre-
Giovannoli and Levy, 2006). At the transcriptome-wide level,
however, splicing changes taking place in human development
and aging have not been investigated. Here, we took advantage
of high-throughput sequencing to assess the extent, functional
significance, and potential regulation of splicing changes
taking place in two brain regions, prefrontal cortex (PFC)
and cerebellum, over the entire human lifespan.
Results
Transcriptome sequencing
To assess changes in gene splicing in the human brain over the
course of lifespan, we sequenced the poly-Aþ transcriptome
in a total of 35 individuals, with ages ranging from 2 days to 98
years, using high-throughput transcriptome sequencing (RNA-
seq) on the Illumina platform. The sequencing was carried out
for the PFC and cerebellar cortex (CBC) of 30 individuals using
the paired-end protocol (Data set 1 (DS1)), and in the PFC of 13
individuals using the single-end strand-specific protocol (Data
set 2 (DS2)). The read length was 75 nucleotides (nt) for DS1
and 100 nt for DS2. In the DS1, poly-Aþ RNA from five
individuals, of similar age per sample, were combined to
reduce individual variation, resulting in six PFC and six CBC
samples (Supplementary Tables S1 and S2, Figure 1A). In DS2,
individual samples were sequenced separately.
In total, we obtained 181 555 729 read pairs in DS1 and
274 927 771 reads in DS2, with the average sample coverage of
18 million reads (Supplementary Table S3). The reads were
Figure 1 Age-related splicing changes in the human brain. (A) Sample age distribution in PFC (orange) and CBC (gray). Each dot represents an individual; the darker
shades of color represent older age. In DS1, five individuals of similar age were combined in each sample, resulting in six PFC- and six CBC-pooled samples with the
average ages marked on the horizontal axis. (B) Fraction of genes (right) and segments (left) showing significant age-related splicing changes in DS1 (DS1 age), DS2
(DS2 age), and in both data sets (DS1 and DS2), as well as genes showing significantly different age-related changes in brain regions in DS1 (DS1 tissue:age). (C)
Correlation of age-related splicing changes between DS1 and DS2. Shown are the distributions of the Pearson correlation coefficients for non-age-related segments
(gray, N¼ 22 360); segments significant only in DS2 (yellow, N¼ 4630); segments significant only in DS1 (orange, N¼ 1648); and segments significant in both data
sets (red, N¼ 1484). In all cases, only segments with sufficient coverage in both data sets were used. (D) Correlation of inclusion ratio changes with age measured by
RT–PCR (horizontal axis) and RNA-seq (vertical axis). (E) Correlation of inclusion ratio estimates measured by RT–PCR (horizontal axis) and RNA-seq (vertical axis). (F)
Correlation of age-related splicing changes measured at the transcript (RNA-seq) and protein (mass spectrometry) levels. Shown are the distributions of the Pearson
correlation coefficients for the actual observations (orange) and 10 000 random permutations (gray). The difference between the means of observed and permutation
distributions was significant (q¼ 0.0004). At the individual segment level, 4 of 24 segments showed marginally significant correlations (Pearson correlation test, BH-
corrected FDRo0.1). (G and H) Examples of age-related splicing changes in PFC for PALM (G) and MART (H) gene transcripts. Shown are: (top) RNA coverage (by all
samples from DS1) and gene annotation (Ensembl, v57); (bottom) RNA (gray) and protein (blue) coverage and annotation of zoomed gene regions in newborns (nb),
young and old individuals (an average of two pooled samples with similar age). The height of the red lines represents the RNA coverage of splice junctions. The PCR
results showing relative abundance of the short (S) and long (L) isoforms for the depicted junctions are displayed to the right of the corresponding coverage plot.
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mapped to the human genome and the splice junctions,
including annotated and hypothetical junctions, were con-
structed by combining exons within a gene based on the
Ensembl annotation (Methods). Allowing up to three mis-
matches, 64% of the reads could be mapped (Supplementary
Tables S3 and S4; Supplementary Figure S1), with 93% of the
mapped reads located within gene boundaries: 85% within
exons, and 25% on the splice junctions (Supplementary Table
S3). Allowing no mismatches during the mapping procedure
did not influence our results (Supplementary Figures S2–S4).
A total of 8365 genes had alternative exons with sufficient
coverage in DS1, and 8061, in DS2 (Methods). A total of 30122
segments from 6755 genes that had sufficient coverage in both
data sets were used in the analysis.
We further identified novel splice variants bymapping reads
to hypothetical junctions constructed based on the Ensembl
exon annotation. In addition to 200 464 annotated splice
junctions, we identified 21 644 novel junctions supported by at
least two sequence reads. There were no detectable deviations
from the uniform junction coverage for either novel or
annotated junctions (Supplementary Figure S5). This finding
indicates that at least 10% of transcript isoforms expressed in
the human brain are not yet annotated.
Age-related splicing variation in the human brain
To identify age-related splicing changes, we defined gene
segments as intervals between nearest splice sites, as well as
transcriptional and translation start/stop sites, based on the
Ensembl annotation (v57). For each segment, two read
categories were counted: reads that map to the segment itself,
that could be termed inclusion reads (i), and reads that map to
junctions between upstream and downstream segments, or
exclusion reads (e). Consequently, the inclusion ratio (i.e., the
proportion of transcripts that contains a segment) was
estimated as
Inclusion ratio¼ i/ðlength ðsegmentÞþ 2length ðreadÞ 1Þ
i/ðlength ðsegmentÞ þ 2length ðreadÞ 1Þ þ e/ðlength ðreadÞ  1Þ
The Binomial Generalized Linear Model was applied to test
the significance of the inclusion ratio change with age
(Methods). Following this approach, 22% of genes detected
in DS1 (3132 segments from 1456 genes) and 38% of genes
detected in DS2 (6114 segments from 2588 genes) demon-
strated significant age-related splicing changes (qo0.05,
Figure 1B). A total of 1484 segments from 721 genes were
significant in both data sets. Only these segments were used in
the further analyses, unless otherwise specified.
The validity of the identified age-related splicing changes
was tested using three approaches. First, we compared the
identified age-related splicing changes between DS1 and DS2.
Even though DS1 and DS2 were generated using alternative
sample preparation and sequencing procedures, age-related
splicing changes found in each data set overlapped signifi-
cantly (Fisher’s exact test, Po0.0001) and displayed strong
and significant positive correlation for the inclusion ratio
changes with age (Figure 1C, Supplementary Table S5).
Second, we measured splicing in all 12 DS1 samples using
Affymetrix Exon Arrays. Segments detected on the arrays and
showing significant age-related splicing changes in DS1, or in
both DS1 and DS2, demonstrated positive and significant
correlation for inclusion ratio changes with age between the
two methodologies both in PFC and in CBC (Pearson
correlation, Po0.0001 in both brain regions) (Supplementary
Figure S6).
Third, we tested the inclusion ratio variation of 30 segments
showing significant age-related splicing changes in both RNA-
seq data sets using PCR. Out of the 30 segments, 24 showed
two PCR bands of a size expected for the predicted splicing
products. All 24 showed inclusion ratio changes with age that
matched the RNA-seq results (r¼ 0.93) (Figure 1D and G–H
Supplementary Table S6). In addition, not only the inclusion
ratio changes with age, but also the inclusion ratio estimates
themselves, demonstrated good overall agreement between
the PCR and RNA-seq protocols (r¼ 0.88) (Figure 1E,
Supplementary Table S6). Taken together, these results
confirm authenticity and reproducibility of the age-related
splicing changes identified by RNA-seq.
Age-related splicing changes at the protein level
Close to 30% of identified age-related splicing changes (26%
in DS1 and 33% in DS2) affect segments annotated as protein-
coding in all transcript isoforms. Thus, if the corresponding
isoforms are translated, these splicing changes should be
observed at the protein level. To test this, we took advantage of
a data set containing protein measurements from PFC of 12
humans with the same age distribution, collected using label-
free mass spectrometry (Somel et al, 2010). Despite the
fragmentary nature of mass-spectrometry coverage, sufficient
peptide numbers were detected for 24 segments from 19 genes
showing significant age-related splicing changes in both data
sets (Methods). Importantly, the age-related splicing changes
correlated positively and significantly between the mRNA and
protein measurements, compared with the correlation coeffi-
cient distribution obtained by permutation of the segment
labels for RNA and protein measurements among the
24 segments (P¼ 0.0006 for DS1; 0.0001 for DS2; 0.0004 for
the integrated DS1/DS2 data set) (Figure 1F). This result
further validates the authenticity of identified age-related
splicing changes, and indicates the presence of corresponding
changes at the protein level.
Splicing changes in development and aging
A previous study showed that gene expression in the human
PFC changes at a rapid pace during early postnatal develop-
ment, but at amuch slower rate in adulthood and aging (Somel
et al, 2010). Here we show that splicing changes in the human
PFC display a similar trend: when classifying changes taking
place before 14 years of age as development, and after 25 years
as aging, B70% of total splicing variation takes place in
development: of the 1484 segments showing significant
splicing changes with age, 970 showed significant changes in
development and 310 in aging, if significance was tested
separately for each ontogenetic interval. Notably, splicing
changes in development and in aging show strong and
opposite directional bias: in development, 75% of segments
showed decreased inclusion, while in aging, 77% of segments
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showed increasing inclusion (Figure 2A). Over lifespan, these
two trends comprised a common ‘down–up’ inclusion ratio
pattern comprising 62% of segments showing significant age-
related changes (Figure 2B). The same bias towards a ‘down–
up’ inclusion ratio pattern was observed when we considered
only segments showing significant splicing changes in devel-
opment and/or aging when testing significance separately for
each ontogenetic interval (Methods; Supplementary Figures
S7 and S8).
Segments following the ‘down–up’ inclusion ratio pattern
displayed a number of distinct features. First, a significantly
greater proportion of ‘down–up’ segments, compared with
segments following other inclusion patterns, represented
retained introns (Fisher’s exact test, Po0.0001; Figure 2C).
The prevalence of retained introns in this splicing pattern
was not caused by mis-mapping artifacts, as is shown by
re-analysis of DS1 and DS2 based on data mapped with
no mismatches (Supplementary Figures S3 and S4).
Consequently, a significantly greater fraction of the ‘down–
up’ segments could be associated with nonsense-mediated
decay (NMD) (Fisher’s exact test, Po0.001; Figure 2D).
Second, the ‘down–up’ segments were significantly less
conserved on the DNA sequence level, compared with
other age-related segments (Wilcoxon test, Po0.0001;
Figure 2E). This lack of sequence conservation was still
present when only retained introns were considered
(Wilcoxon test, Po0.0001). Taken together, these features
indicate that a fraction of gene segments, preferentially
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Figure 2 Splicing changes in development and aging. (A) Distribution of the inclusion ratio change index for development (solid line) and aging (dash line) for 1484
age-related segments. The negative index represents the inclusion ratio decrease with age, positive index, the inclusion ratio increase. The colors represent RNA-seq
data sets analyzed: yellow—DS1/PFC, gray—DS1/CBC, and red—DS2/PFC. (B) Scatter plot of the inclusion ratio change showing different splice types: violet—skipped
exons, yellow—retained introns, gray and white—complex and mixed splice types respectively. Four quadrants of the plot correspond to four patterns of inclusion ratio
change with age: down–up, up–up, up–down and down–down. Inclusion ratio change is plotted for the 853 segments showing significant splicing changes with age in
both data sets and showing consistent direction of age-related splicing change between data sets in development, as well as in aging. (C) Schematic representation of
segment numbers (represented by the size of the pie diagrams) and splicing type fractions (represented by colors) in the four inclusion ratio change patterns shown in
panel B. (D) Fractions of NMD segments in the four inclusion ratio change patterns. Numbers on top of the bars show the number of NMD segments and the total number
of segments in each pattern. Asterisks indicate significant enrichment of NMD segments in the ‘down–up’ pattern (one-sided Fisher’s exact test, P¼ 0.0002) (E)
Distribution of the phastCons scores of segments in the four inclusion ratio change patterns. Asterisks indicate significantly low conservation of segments in the ‘down–
up’ pattern (one-sided Wilcoxon test, Po0.0001). (F–K) Gene expression of NMD-related genes, CASC3, UPF2, UPF3B, SMG1, SMG5, and SMG6 in the human PFC.
Gene expression was estimated based on published data from (Liu et al, 2012) (green) and (Colantuoni et al, 2011) (violet). Expression intensities for each gene were
normalized to mean¼ 0 and s.d.¼ 1. Age scale is log2-transformed, ages are shown in years, MAC stands for ‘months after conception’.
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incorporated in early development and late aging, might target
these transcripts for NMD.
To test this notion, we assessed the expression of genes
involved in the NMD pathway. Of the 21 genes annotated in
this pathway (Chang et al, 2007), 15 were expressed in the
brain (Colantuoni et al, 2011; Liu et al, 2012) and 6 (UPF2,
UPF3b, SMG1, SMG5, SMG6 and CASC3) showed significant
age-related expression changes (F-test Po0.01; permutation-
based FDRo0.05). Of these six genes, five showed decreased
expression in development and increased expression in aging;
a profile closely resembling the profile of NMD-associated
segments (Figure 2F–K). Finding so strong correlation is
unexpected (Fisher’s exact test, Po0.02) and supports the role
of the ‘down–up’ segments in triggering NMD.
Age-related splicing changes at rhesus macaque
homological segments
To determine the reproducibility of the age-related splicing
patterns identified in the human brain, we measured RNA
splicing patterns in the PFC of 15 rhesus macaques with ages
distributed between 1 day and 28 years, using RNA-seq
(Supplementary Table S7). Among the 1484 segments sig-
nificant in the two human data sets, 496 could be mapped
unambiguously to the rhesus macaque genome and had
sufficient sequence read coverage. When comparing human
and macaque age-related splicing patterns based on the
inclusion ratio trajectories of these 496 segments, we observed
significantly greater positive correlations than expected by
chance (permutation test, Po0.005). Further, if we consider
development and aging separately, splicing changes of 321 (of
the 496) segments that were significant in development, and
131 segments significant in aging, were consistent between the
human and macaque data sets for each of these ontogenetic
intervals (Fisher’s exact test, Po0.0001 for development and
Po0.005 for aging).
We further tested the consistency of the four main splicing
patterns observed in the human PFC, between the human and
the macaque data sets. All four main splicing patterns showed
significantly greater positive correlations between the human
and macaque trajectories of splicing changes with age,
independent of the segment selection criteria (mean r between
0.4 and 0.6; permutation test, Po0.005) (Supplementary
Figure S9).
Age-related splicing patterns
Gene expression changes found in the human brain over the
course of lifespan show discrete patterns (Somel et al, 2010).
The age-related splicing changes identified here did not
correlate with gene expression changes (Supplementary
Figure S10), but displayed discrete splicing patterns. Non-
supervised hierarchical clustering of age-related splicing
changes in DS1 and DS2 revealed eight main clusters contain-
ing 1422 out of 1484 segments (hereafter referred as CL1–8)
(Figure 3A, Supplementary Figure S11). Splicing patterns in all
eight clusters showed good agreement between the two data
sets (Figure 3A).
Functional analysis of genes falling into the eight clusters,
using GO biological process taxonomy (Ashburner et al, 2000)
and Kyoto Encylopedia of Genes and Genomes (KEGG)
pathways (Kanehisa et al, 2010), revealed significant func-
tional enrichment in three clusters: CL6, CL7, and CL8.
Notably, both CL6 and CL8 were enriched in genes associated
with neural functions, including GO terms ‘synaptogenesis’,
‘behavior’ and ‘learning’ in CL6 and ‘regulation of synaptic
transmission’ and ‘regulation of neurogenesis’ in CL8
(Supplementary Table S8).
To test whether the identified age-related splicing changes
within each cluster could be regulated by SFs, we searched for
enrichment in 36 candidate SF-binding motifs (SFBMs) within
the 300bp regions up- and downstream of segment bound-
aries. We found that five out of eight clusters (CL1, CL3, CL6,
CL7, and CL8) demonstrated greater enrichment of SFBMs
than expected by chance (permutation-based FDRo0.2)
(Figure 3B). Furthermore, in all five clusters, the expression
profiles of the corresponding SFs showed significantly better
correlation with the splicing profiles of their target segments
than expected by chance (permutation-based FDRo0.2)
(Figure 3B). Thus, the observed age-related splicing changes
could in part be explained by expression changes of the
corresponding SFs. It should be noted that, due to the low
reliability of computational SFBM identification, our results
are likely to underestimate the role of SFs in the regulation of
age-related splicing changes (Barash et al, 2010).
Even with the limited annotation available, several notable
associations between SFs and age-related splicing patterns
could be observed. In the biggest of all clusters, CL1,
corresponding to the ‘down–up’ splicing pattern, the expres-
sion level of 8 of the 10 SFs with binding site enrichment in this
cluster showed a positive correlation with the inclusion ratio
pattern in this cluster, with the remaining 2 SFs showing
negative correlation (Figure 3B). Finding such numbers of
positively and negatively correlated SFs is unexpected (Fish-
er’s exact test, Po0.001) and indicates a potential regulatory
relationship between the expression of these SFs and the
predominant ‘down–up’ splicing pattern we observe in the
human brain over the course of lifespan. Among SFs that
showed significant SFBM enrichment and positive correlation
with the inclusion ratio profiles of CL1 segments are the
polypyrimidine tract-binding proteins PTBP1 and PTBP2, as
well as other heterogeneous nuclear ribonucleoproteins,
including hnRNPA1, hnRNPH1, hnRNPH3 and hnRNPHF
(Figure 3C–H, Supplementary Table S9). Notably, PTBP2
expression is specific to the brain (Andres et al, 1999) and
both PTBP1 and PTBP2 were shown to function in neuronal
development (Grabowski, 2011) and glioma proliferation
(Cheung et al, 2009). Further, formation of a protein complex
containing PTBP1, PTBP2 and HNRNPH1, as well as coopera-
tive RNA binding by PTBP2 and hnRNPH1 has been
demonstrated (Markovtsov et al, 2000).
Gene segments in CL6, a cluster associated with the GO
terms ‘learning’, ‘behavior’, and ‘synaptogenesis’, showed
significant SFBM enrichment, but negative correlation with
the expression profiles of hnRNPH1, hnRNPH3, and
hnRNPHF. Similarly, gene segments in CL8 associated with
the regulation of neurogenesis and synaptic transmission
showed significant SFBM enrichment, but negative correlation
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with the expression of PTBP1 and PTBP2. Previous research
has shown that the location of PTBP1/PTBP2-binding sites
upstream or downstream of the spliced segment may result in
preferential inhibition or activation of the segment inclusion
(Llorian et al, 2010). Negative association between the PTBP1/
PTBP2 expression and CL8 splicing pattern could be further
confirmed in our study using exons experimentally annotated
to be repressed or activated by the PTBP1/PTBP2 in HeLa cells
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(Llorian et al, 2010). The experimentally annotated exons were
significantly over-represented in CL8 (one-sided Fisher’s exact
test, P¼ 0.002, odds ratio¼ 6.8). Notably, in agreement with
the negative association between the PTBP1/PTBP2 expres-
sion and the CL8 splicing pattern, all experimentally annotated
exons present in CL8 were repressed by PTBP1/PTBP2 in the
cell line (one-sided Fisher’s exact test, P¼ 0.001, odds
ratio¼ 7.8).
Age-related splicing differences between cortex
and cerebellum
For the vast majority of gene segments, age-related splicing
changes in one of the brain regions correlated positively and
significantly with age-related splicing changes in the other
brain region studied (Figure 4A). Still, of the 3132 segments
showing age-related splicing changes in DS1, 15% differed
significantly in their age-related splicing patterns between the
PFC and CBC (qo0.05). Differences in age-related splicing
patterns between the two brain regions identified by RNA-seq
were further validated using Affymetrix Exon Arrays
(Supplementary Figure S12). Some of these differences affect
genes associated with neural functions, such as amyloid beta
(A4) precursor protein (APP), which is involved in Alzhei-
mer’s disease (Supplementary Figure S13), bridging integrator
1 (BIN1), which is involved in synaptic vesicle endocytosis
(Supplementary Figure S14), or protocadherin gamma
(PCDHG), shown to be associated with cell adhesion and
synapse formation (Frank et al, 2005; Garrett and Weiner,
2009). Notably, all three major isoform exons of PCDHG have
distinctively different age-related splicing patterns in the PFC
and CBC (Figure 4B and C). Further, splicing changes with age
of PCDHG transcript in the human PFC resembled splicing
changes reported in the developing mouse brain (Frank et al,
2005), indicating their evolutionary conservation.
Discussion
We have shown that close to 40% of genes expressed in the
human brain experience significant splicing changes over
postnatal lifespan. As our study is limited to two brain regions
and is based on a relatively small number of individuals, it is
likely to underestimate the total extent of age-related splicing
changes in the human brain. Although functional importance
of these changes is not addressed in our study, B30% of
identified age-related splicing changes affect the protein-
coding portion of the transcript. Although the power of our
assay was limited due to the relatively low coverage of the
protein mass-spectrometry data, for proteins with sufficient
peptide coverage, these age-related splicing changes could still
be directly observed at the protein sequence level. Notably,
many of the genes with splicing changes confirmed at the
protein level were previously implicated in neural functions
and dysfunctions. These include: MAPT associated with
several neurodegenerative disorders including Alzheimer’s
disease, frontotemporal dementia, and cortico-basal degen-
eration (Wang and Liu, 2008); NDRG2 implicated in Alzhei-
mer’s disease (Mitchelmore et al, 2004) and potentially
involved in the stimulation of neurite outgrowth (Takahashi
et al, 2005); NPTN, an adhesion protein involved in the long-
term potentiation pathway (Smalla et al, 2000; Bernstein et al,
2007); PALM involved in axonal and dendritic outgrowth,
dendritic spine maturation and synapse formation (Kutzleb
et al, 1998); and PTPRZ1 potentially involved in the regulation
of CNS development (Levy et al, 1993).
Close to 70% of age-related splicing changes take place
during development (0–14 years) with the remaining 30%
occurring in aging (25–98 years). This is similar to results
previously obtained at the gene expression level (Somel et al,
2010). In contrast to gene expression changes, which show
approximately equal proportions of increased and decreased
expression in both development and aging, age-related
splicing changes show strong directional asymmetry: 75% of
segments showed decreased inclusion during development,
while 77% of segments showed increasing inclusion in aging.
As the result, the majority of age-related splicing changes
detected in the human brain represent a common pattern
reflecting preferential inclusion of certain gene segments in
infancy and at a very old age. A larger than average proportion
of these inclusion events represent intron retention, and are
expected to target the transcripts for NMD. It is therefore
notable that five of the six NMD pathway members, that show
age-related gene expression changes in the human brain, also
show elevated expression in infants and old adults. Splicing
pattern similarity between infants and elderly is unexpected.
Molecular changes occurring at old age are thought to have
deleterious effects, as such changes do not impact on the
individual’s reproductive success, and could accumulate
rapidly within a population (Brian, 1946, 1952). By contrast,
Figure 3 Patterns and regulation of age-related splicing changes. (A) Age-related splicing patterns in the PFC (orange) and CBC (gray). The horizontal axis shows the
samples’ ages in years. The vertical axis shows the inclusion ratio normalized to mean¼ 0 and s.d.¼ 1 for each segment in each brain region. The points represent the
mean inclusion ratios of segments within each pattern in each sample. The lines and the error bars show the cubic spline curves of the mean inclusion ratios and the s.d.
of the curves, respectively. The colors represent RNA-seq data sets analyzed: yellow—DS1/PFC, gray—DS1/CBC, and red—DS2/PFC. The numbers above the panels
show the ID and the numbers of segments and genes in each pattern. The percentages shown within the panels indicate the percentage of splicing variation found in
development and in aging. The vertical dotted line indicates separation between developmental and aging intervals. Numbers of segments separately significant in
development or in aging are shown at the bottom of the panels. (B) Top: numbers of SFs with significant enrichment of SFBM in a given pattern (Fisher’s exact test,
Po0.05) (gray bars). The striped bars represent the median numbers of SFs expected by chance, calculated by randomly assigning the same numbers of age-related
segments to each pattern 1000 times. The symbols above each bar indicate the significance levels of the permutation-based FDR (***—FDRo0.05, **—FDRo0.10,
*—FDRo0.20). Bottom: numbers of SFs with significant SFBM enrichment and positive (red) or negative (blue) correlation between the SF expression profile and the
inclusion ratio profiles of the segments containing these SFBM within a pattern, compared with the segments from other patterns (one-sided Wilcoxon test, Po0.05).
The striped bars represent the median numbers of correlated SFs expected by chance, calculated by randomly assigning the same numbers of age-related segments to
each pattern 1000 times. (C–H) Gene expression of SFs, PTBP1, PTBP2, hnRNPA1, hnRNPF, hnRNPH1, and hnRNPH3, in the human PFC. Gene expression was
estimated based on published data from (Liu et al, 2012) (green) and (Colantuoni et al, 2011) (violet). Expression intensities for each gene were normalized to mean¼ 0
and s.d.¼ 1. Age scale is log2-transformed, ages are shown in years, MAC stands for ‘months after conception’.
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any deleterious changes taking place in early postnatal
development would have a strong negative effect on the
individual’s fitness, and will be eliminated quickly from a
population. Therefore, beneficial and deleterious effects of the
NMD increase in the infant and aging human brain remain to
be investigated.
Mechanistically, similarity of splicing patterns at young and
old age could be caused by consistent changes in the
expression of the corresponding SFs. Analysis of major
splicing patterns indicates that gene segments showing
inclusion decrease in development and increase in aging
(CL1) are significantly enriched in the candidate-binding sites
of 10 SFs: PTBP1, PTBP2, hnRNPA1, hnRNPH1, hnRNPH2,
hnRNPH3, hnRNPHF, Tra2b, SC35, and SRp40. Notably, for all
10 SFs, age-related expression changes correlated significantly
with the CL1-splicing profile: positively for 8 and negatively
for 2 SFs (Supplementary Table S9), while at most 1 would be
expected to correlate by chance. Similar enrichment of SFBMs,
and correlation between the expression profiles of SFs and
their target segments, could be observed in a total of five out of
eight splicing clusters. Overall, more than 50% of age-related
splicing changes could be linked to expression changes of the
corresponding SFs. Given the rather low reliability of the SFBM
identification (Barash et al, 2010), the role of SFs in the
regulation of age-related splicing changes is likely to be even
greater.
The age-related splicing changes detected using RNA-seq
measurements was verified by cross-validation of two
independent human and one rhesus macaque RNA-seq data
sets, reanalysis of the entire DS1 using Exon Arrays, testing
selected splicing changes using PCR, and detecting splicing
changes at the protein level. Taken together, the results we
obtained using these diverse techniques provide strong
support for the robustness and authenticity of our results.
Verification of age-related splicing changes in the rhesus
macaque data set is particularly notable as, in contrast to
humans, all rhesus macaque samples were obtained from the
same primate facility where animals were raised in the same
environment. Thus, this additional data set addresses all
possible confounding variables caused by sample heterogene-
ity in the human data. Furthermore, close correlation between
the human and the macaque patterns of splicing changes with
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Figure 4 Age-related splicing changes in PFC and CBC. (A) Correlation of age-related splicing changes between the PFC and CBC in DS1. Shown are distributions of
the Pearson correlation coefficients for 24 458 segments with sufficient coverage in both data sets but not significant in DS1 (gray), and for 3132 segments showing
significant age-related splicing changes in DS1 (red). (B) Age-related splicing changes in the protocadherin gamma transcript in the human PFC and CBC. RNA-seq
coverage in all 12 DS1 samples is shown. (C) Inclusion ratio profiles of the protocadherin gamma C3-C5 exons. The colors represent the RNA-seq data sets analyzed:
yellow—DS1/PFC, gray—DS1/CBC, and red—DS2/PFC. The points represent the inclusion ratios and the lines represent the cubic spline curves fitted with three
degrees of freedom.
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age (Supplementary Figure S9) indicates that these changes
are evolutionarily conserved, thus implying potential func-
tionality. With respect to possible pitfalls in data analysis,
removal of potentially mis-mapped reads using more stringent
mapping criteria did not influence our results either for all the
age-related splicing changes (Supplementary Figure S2) or,
specifically, for age-related changes in intron retention
(Supplementary Figures S3 and S4).
Among the remaining confounding variables, we considered
the influence of sex, ethnicity, tissue composition, and RNA
quality. This study was not designed to estimate sex-related
splicing differences in the human brain. Accordingly, DS1
samples contained both male and female individuals in every
sample pool. By contrast, DS2 contained 11 male and 2 female
samples (age: 19 days and 2 years) (Supplementary Table S2).
There was no detectable effect of these two samples on the
statistical analysis, and age-related splicing changes showed
high positive correlation between DS1 and DS2. Further,
multidimensional scaling analysis based on splicing variation
in DS1 and DS2 indicated that splicing variation in both data
sets was strongly influenced by age, whereas both sex and
ethnicity had no detectable effect (Supplementary Figure S15).
To further test the influence of the samples’ ethnicity on age-
related splicing changes, we estimated the rates of age-related
splicing changes in five African-American samples and five
Caucasian samples with similar age distributions (see Meth-
ods). Despite the small number of samples tested, our results
demonstrated a good agreement for splicing changes with age
between these two ethnicities (r¼ 0.75, Po0.0001)
(Supplementary Figure S16). Thus, splicing differences
between the sexes and/or ethnicities in the human brain
could not be assessed in our data, and did not have a detectable
effect on the identified age-related splicing changes.
Tissue composition in general, as well as tissue composition
changes with age, differs greatly between PFC and cerebellum.
By contrast, the vast majority of age-related splicing changes
are shared between these brain regions (Figure 4A). Further-
more, there was no enrichment of genes preferentially
expressed in specific brain cell types (neurons, astrocytes,
oligodendrocytes, and oligodendrocyte precursors) (Cahoy
et al, 2008) or in the gray or white matter (Erraji-Benchekroun
et al, 2005) among any of the eight main splicing patterns
(Supplementary Table S10). Thus, the observed age-related
splicing changes are unlikely to be caused by changes in tissue
composition.
RNA degradation would result in shortening of the captured
transcripts and, consequently, greater 30-coverage bias.We did
observe some 30-coverage bias in both data sets
(Supplementary Figure S17). The differences in the coverage
bias among samples, however, did not show any significant
association with age.
Finally, our experimental design allowed us to effectively
remove false positives caused by biological variability; almost
all our analysis is based on segments that are significant in two
independent data sets. In addition, we used CBC samples from
DS1 to focus on age-related splicing changes that were
consistent between the two brain regions.
Taken together, these results strongly suggest that the
identified age-related splicing changes are real. Although
splicing changes in individual genes have been previously
shown to have important roles in the brain development
(Dredge et al, 2001; Ule et al, 2005; Blencowe, 2006), our study
demonstrated that thousands of yet uncharacterized splicing
changes take place in the PFC and cerebellum during human
brain development, maturation, and aging. Investigating the
implications of these changes on the establishment, and
deterioration, of human cognitive functions over the course of
lifespan will be a formidable, but necessary, task.
Materials and methods
Sample collection
PFC and CBC samples were dissected from postmortem brains of 30
(DS1) and 13 (DS2) humans (aged 0–98 years) (Supplementary Tables
S1 and S2). Human samples were obtained from the NICHD Brain and
Tissue Bank for Developmental Disorders at the University of
Maryland, USA, the Netherlands Brain Bank, Amsterdam, the
Netherlands. Informed consent for the use of human tissues for
research was obtained in writing from all donors or from their next of
kin. All subjects were defined as normal by forensic pathologists at the
corresponding brain bank. All subjects suffered sudden death with no
prolonged agonal state. Rhesus macaque samples were obtained from
the Suzhou Experimental Animal Center, China.Macaques used in this
study suffered sudden deaths for reasons other than their participation
in this study and without any relation to the tissue used. CBC
dissections were made from the lateral CBC. PFC dissections were
made from the frontal part of the superior frontal gyrus. All samples
contained anB2:1 gray matter to white matter volume ratio.
RNA sequencing
For DS1, samples were prepared by pooling equal quantities of total
RNA from five individuals of similar age (Supplementary Table S1;
Figure 1A). In all cases, PFC and CBC samples were dissected for the
same individuals. All samples had a comparable, and good, RNA
quality (Supplementary Table S1). RNA was isolated using Trizol
reagent (Invitrogen, Carlsbad, CA). Oligo(dT) selectionwas performed
twice using Oligotex mRNA Midi Kit (Qiagen). After selection, 100 ng
mRNA was first fragmented by addition of 5 fragmentation buffer
(200mM Tris acetate, pH 8.2, 500mM potassium acetate, and 150mM
magnesium acetate) with heating at 94 1C for 2min 30 s in a
thermocycler. The fragments were then transferred to ice and run
over a Sephadex-G50 column (USA Scientific) to remove the
fragmentation ions. We used random hexamer primers (Invitrogen,
cat. no. 48190-011) for reverse transcription of fragmented mRNA to
double-strand cDNA. Sequencing libraries were prepared according to
the paired-end non-strand-specific sample preparation protocol
(http://www.illumina.com). Each sample was sequenced in a
separate lane in the Illumina Genome Analyzer II system, using the
75-bp paired-end sequencing protocol.
RNA libraries for the human DS2 and for the rhesus macaque data
set were constructed according to the Illumina strand-specific RNA-seq
library preparation procedure. Briefly, 100 ng fragmented mRNA was
first treated with phosphatase, and then consecutively ligated to v1.5
small RNA 30 and 50 adapters. After reverse transcription and 15 cycles
of amplification, the library was sequenced using Illumina small RNA
sequence primers to the length of 100 bp. All sequence data are
available at the Sequence Reads Archive, and the study accession is
SRP005169.
Defining gene segments
Segments were defined as intervals between nearest segmentation
sites, that is, splice sites and transcriptional and translation start/stop
sites based on the Ensembl (Flicek et al, 2010) annotation (v57).
Segments were further classified according to their location in
(a) constitutive exons (segments annotated as exons in all isoforms),
(b) constitutive introns (segments annotated as introns in all
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isoforms), and (c) alternative regions (segments annotated as exons
and introns in different isoforms). In total, 366163 segments were
classified as constitutive exonic, 246 080 as constitutive intronic, and
157177 as alternative.
For the subsequent analysis, we only retained segments frommulti-
exon, nuclear, and protein-coding genes with a total length of
constitutive coding sequence of at least 100 nt (19 383 genes). Only
segments overlapping with a gene region annotated as a protein-
coding region (CDS) in at least one isoform were retained. We further
excluded all segments classified as constitutive intronic. Thus, un-
annotated intron retention events could not be detected in our
analysis. Instead, alternative segments that had exactly the same
coordinates as introns (annotated intron retention events) were
considered as retained introns. Only segments with at least 10
inclusion and 10 exclusion reads in each data sets were used in the
analysis. Segments with stop codons more than 50 nt upstream of the
next splice site in all usable reading frames were considered as NMD
segments. Alternative segments surrounded by two constitutive or
retained introns were considered to be skipped exons. The remaining
alternative segments were classified as complex alternatives.
Construction of the artificial splice junction library
We generated an artificial splice junction library by connecting the two
neighboring exons in all annotated isoforms (known junction
sequences) and the two non-neighboring exons (novel junction
sequences) using the Ensemble annotation (v57). Considering the
read to be 75- and 100-nt-long, short junction sequences (o75 nt) were
merged to adjacent exons until a length of 75 nt was reached. The
remaining short junction sequences that could not be merged were
filtered out. In total, the constructed junction library contained 302179
known and 2 267 677 novel splice junction sequences.
Mapping
Read pairs containing low-quality nucleotides, as defined by the
Illumina sequencing procedure, were filtered out. The remaining reads
were mapped to the human reference genome (hg19) and the artificial
splice junction library using the Bowtie software (Langmead et al,
2009) with the following parameters: ‘ k 20–best –strata’ and
allowing a maximum of three mismatches. We required a minimum
of a 6-nt overhang for reads that mapped to exon junction sequences.
In DS1, if only one read from a pair could be mapped, the other read
from this pair was truncated at 30-end to the length of 38 nt (one half of
the sequence) and mapped again using the same parameters. If the
truncated read still could not be mapped, the read pair was discarded.
Upon completion of themapping procedure, all possible combinations of
read pair locationswere constructed for each pair. Next,we only retained
the locations with paired reads that were on different strands of the same
chromosome, with a distance between reads not exceeding 1Mb. Read
pairs that had only one valid location were considered as uniquely
mapped. Only uniquely mapped reads were used for further analysis.
In DS2, only reads that could be uniquely mapped to the human
genome or splice junctions, using the above procedure, were retained.
Novel splice junctions
All exon combinations not included in isoforms listed in the Ensembl
annotation (v57), but supported by at least two (DS1) or are least four
(DS2) independent reads (reads with the genome coordinates over-
lapping by less than 100%), that mapped over the splice junction with
at least a 6-nt overhang, were classified as novel junctions.
Inclusion ratio
To estimate the splicing extent for each segment, we calculated the
segment inclusion ratio as:
Inclusion ratio¼ i/ðlength ðsegmentÞ þ 2length ðreadÞ 1Þ
i/ðlength ðsegmentÞþ 2length ðreadÞ 1Þþ e/ðlength ðreadÞ 1Þ
where i is the number of inclusion reads (i.e., reads that overlap with
the segment), e is the number of exclusion reads (i.e., reads that
mapped to the junction that spans the segment), length (segment) is
the segment length in nucleotides and length (read) is the read length
in nucleotides. Here, the numerator is proportional to the number of
mRNA molecules that contained the segment and the denominator is
proportional to the number of mRNA molecules that did not contain
the segment. For DS2, only reads that mapped to the sense strandwere
used in the coverage calculation. For exon arrays, the inclusion ratio
was calculated as the segment intensity divided by the gene intensity.
For protein data, the inclusion ratio was calculated as peptide counts
within a segment divided by peptide counts within a gene. For all
samples, only segments with iþ eZ5 were considered to have
sufficient read coverage.
Statistical analysis of splicing based on RNA-seq
segment coverage
Let {ij} and {ej} represent the sets containing the total numbers of
inclusion and exclusion reads for sample j, respectively (in DS2 only
reads that mapped to the sense strand were used). It is possible to
consider {ij} and {ej} as results of a binomial trial, where {ij}
represents the number of successes and {ej}, the number of failures.
To estimate age-related inclusion ratio changes and differences
between the two brain regions in DS1 and age-related inclusion ratio
changes in DS2, the followingmodelswere fitted using the Generalized
Linear Models function in R, with a logit link function:
ij; ej
   brain regionþ ageþ age2 þ age : brain regionþ age2 : brain region;
ij; ej
   ageþ age2 ;
where brain region is categorical variable and age is continuous
variable equal to power of 0.25 of donor age.
Significance of each termwas estimated by analysis of deviance (log-
likelihood test) followed by the Benjamini–Hochberg correction
(Benjamini and Hochberg, 1995), with qo0.05. Segments with
significant age terms, either linear or quadratic, were considered to
be age-related.
The method to analyze splicing described here is converted into a
stand-alone java-application and R package and freely available at:
http://www.bioinf.fbb.msu.ru/Bmazin.
Additional analysis was performed to find segments where splicing
changes significantly during development (before 25 years) and in
aging (after 25 years) in DS2. For each period, five samples were
chosen to achieve equal power: samples with Brain Bank IDs
Maryl_779, Maryl_759, Maryl_1281, 1453 and 1908 were used to test
splicing changes in development and samples with Brain Bank IDs
605, 1496, S06/117, S01/118, S00/047 were used to test splicing in
aging (Supplementary Table S2). For each ontogenetic period, linear
binomial regression to age0.25 was applied, followed by the Benjamini–
Hochberg correction. Segments with qo0.05 were considered
significant.
To estimate the effect of ethnicity on age-related splicing changes,
five African-American samples (Brain Bank IDs: Maryl_779,
Maryl_1281, 1453, 1275, 605) and five Caucasian samples (Brain
Bank IDs: Maryl_1157, Maryl_759, Maryl_1055, 1908 and 1496) with
similar age distributions were selected from DS2. For each segment, a
linear fit between inclusion ratio and age0.25 was performed using lm
function in R for each ethnicity separately. Calculated linear model
slopes were used to assess the agreement between ethnicities.
Inclusion ratio correlation between DS1 and DS2
For each segment, a cubic spline curvewas fitted to the inclusion ratios
obtained in DS2, with three degrees of freedom. Based on this curve,
the inclusion ratio values at points matching ages of samples fromDS1
were interpolated. The inclusion ratios obtained from DS1 (PFC) and
interpolated in DS2 were used to calculate the Pearson correlation
(Figure 1C).
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Microarray processing and analysis
RNA isolation, hybridization to microarrays, and data preprocessing
were performed as described previously (Somel et al, 2010). Briefly,
total RNA was extracted from the same brain samples using Trizol
reagent (Invitrogen) and purified with the QIAGEN RNeasy MiniElute
kit. RNA quality was assessed with the Agilent 2100 Bioanalyzer
system (Supplementary Table S1). For each sample, 2mg of isolated
pooled RNAwas used for sample preparation, followed by hybridiza-
tion to Affymetrix Human Exon 1.0 ST arrays, according to the
standard protocol with no modifications (http://www.affymetrix.
com). Before hybridization data analysis, all microarray probes were
aligned to the human reference genome (hg19) using the Bowtie
software (Langmead et al, 2009). Only probes uniquely matching the
human genome perfectly were included in the analysis. Probe
intensities were exacted, background corrected, and quantile normal-
ized using the R package ‘affy’ (Gautier et al, 2004). Probes with
intensityo100 were excluded from analyses.
To calculate the expression level of gene segments, array probes
were mapped to segments. If more than half of the probe length was
locatedwithin a segment, then the probewas assigned to this segment.
In caseswhere a probe could bemapped tomultiple segments, we gave
priority to exonic segments. The expression levels of segments were
summarized by the median polish function in the R package ‘affy’. The
expression level of a gene was calculated as an average intensity of
segments located within the coding region of this gene. All microarray
data is deposited in the GEO database (accession GSE26586).
To test the significance of age-related splicing changes based on
array data, linear regression followed by ANOVA was applied. The
following model was used: inclusion ratioBtissueþ ageþ tissue:age,
where tissue denotes either PFC or CBC and age denotes donor age
measured at the quadratic root power scale. Because of the low
number of samples, no segments were significant at FDRo5%. As
array data was not used to identify age-related splicing changes, but
only to verify the ones identified using RNA-seq data, we used a
relaxed ANOVA significance cutoff (Pp0.1) to filter out segments with
low signal-to-noise ratio.
To validate the differences in age-related splicing changes between
PFC and CBC measured using RNA-seq and Affymetrix Exon Array
(Supplementary Figure S11), Pearson correlation coefficients have
been calculated between PFC/CBC inclusion ratio differences mea-
sured by RNA-seq and Exon Arrays (I(PFC,RNA-seq) I(CBC,RNA-seq) and
I(PFC,Exon Array) I(CBC,Exon Array)) for each of 601 segments showing
significant age-related splicing changes in DS1 and showing trend of
change in the Exon Array data ANOVA analysis for the ‘age’ and/or
‘age:tissue’ terms as described above. The I(Tissue,Platform) term denotes
the inclusion ratio value of a given tissue and a given platform.
Validation of splicing changes by PCR
First-strand cDNA was synthesized using SuperScript II reverse
transcriptase (Invitrogen), using the same pooled PFC RNA samples
that were used for the RNA-seq DS1 as templates. To check the
inclusion ratio change of each selected segment, a primer pair was
designed at the two flanks of the segment, and two or three appropriate
DS1 samples were used. PCR reactions were performed at 94 1C for
2min followed by 30 cycles of 95 1C for 20 s, 72 1C for 30 s, and 72 1C for
5min with rTaq DNA polymerase (TAKARA). Then 5ml of each PCR
product were used for electrophoresis in a 2% (w/v) agarose gel. The
size of the fragments was estimated using visual estimation based on
DL 2000 DNA marker (TAKARA). After ethidium bromide (EB)
staining, 24 out of the total of 30 segments tested by PCR showed
two bands with expected product lengths. For the remaining 6 splicing
events tested, we did not observe two PCR bands of expected size.
These PCR products could not, therefore, be used to calculate changes
in inclusion ratio with age. Some of these failed PCRs may indicate
errors in our splicing variant predictions, whereas others might result
from technical failure. The primer sequences of the 24 valid PCR are
listed in Supplementary Table S12. The PCR band intensity quantifica-
tion was carried out using the ‘Trace Qty’ method in the Quantity One
program. In brief, after auto-scaling the image, correcting the back-
ground, and detecting the bandmanually, band intensity was assigned
by the ‘Trace Qty’ method. Then, the inclusion ratio was calculated
based on the PCR band intensity as Ql/(QlþQs), where Ql and Qs are
the intensity values of long and short products, respectively. The
inclusion ratio changes used to check the correlation between RT–PCR
and RNA-seq (Figure 1D) were defined as the RT–PCR or RNA-seq
inclusion ratio differences between the two samples tested in RT–PCR.
For the segments where three or more samples were tested for RT–
PCR, only the two samples with maximum and minimum RNA-seq
inclusion ratio were used.
Protein data processing and analysis
In total, 1 301042 peptide mass spectrum scans from human PFC
samples taken from 12 healthy individuals of different ages (0–98
years) were obtained from Somel et al (2010). The peptides were
identified by searching against a custom peptide library. This library
was created by constructing unique peptides separated by trypsin-
sensitive recognition sites among 1484 segments, from 721 genes, with
significant age-related splicing change both in DS1 and DS2. The
peptides with length o6 amino acids were ignored. The resulting
custom library contained 18 029 peptides based on these 341 genes.
The decoy library, used to estimate the FDR, was created by randomly
shuffling amino acids within each peptide sequence of the custom
peptide library but retaining the terminal lysine and arginine. Using the
InsPecT (Tsur et al, 2005) peptide identification algorithm, followed by
the MS-GF program (Kim et al, 2009), 144 645 peptide counts from
18 014 unique peptides were identified at FDRp0.05.
To ensure sufficient peptide coverage, we required a minimum of 8
peptide counts per protein in each of the 12 samples. In addition, we
required that at least one segment showing inclusion ratio changes
with respect to age, and at least one constitutive segment, were
covered by at least 3 peptide counts each in at least 2 out of 12 samples.
As the peptide coverage along the genes is extremely fragmentary, only
24 segments from 19 genes, supported by 5903 peptide counts,
corresponding to 168 unique peptides, satisfied these criteria.
To calculate the Pearson correlation between the age-related
inclusion ratio changes detected at the protein and RNA levels, the
first problem is that ages are not consistent between the RNA-Seq and
protein data. Therefore, for DS1, we used the inclusion ratios
calculated for six PFC DS1 samples based on the RNA-seq data, and
interpolated the inclusion ratios calculated according to the peptide
coverage. The peptide inclusion ratios were interpolated at six age
points, corresponding to the average ages of six pooled samples,
by fitting a quadratic regression curve to the inclusion ratio in the
12 differently aged individual samples. For the integrated data set of
DS1 and DS2, the RNA-seq inclusion ratios of total 19 ages were fitted
to a quadratic regression curve, then interpolated at 12 age points
corresponding to the protein samples. For DS2, 10 samples were
analyzed using both RNA-seq and the peptidemass spectrum. These 10
shared samples were used for the correlation calculation. The
background distribution was obtained by 10 000 random permutations
of segment labels for the 24 segments followed by the correlation test.
For each data set, the permutation test P-valuewas calculated based on
the distribution of the mean values of the correlation coefficients
obtained in the permutations.
Splicing changes in development and aging
We used the inclusion ratio change index to illustrate the splicing
change extent and the direction of the inclusion ratio change in
development and aging for each age-related segment. First, we
classified 6 ages of DS1 and 13 ages of DS2 as ‘newborn’, ‘young’,
and ‘old’. The pools 3 and 4 of DS1 (average age: 18 and 25 years), as
well as the samples 8 and 9 from DS2 (ages: 13 and 25 years) were
assigned to the ‘young’ category. In DS1, each of the remaining two
newborn samples i and two old samples j can be used to calculate
DdevelopmentðiÞ¼ IRnewbornðiÞ  IRyoung and DagingðjÞ¼ IRyoung IRoldðjÞ,
where IRyoung is the mean of inclusion ratios of the two ‘young’
samples. Setting Ddevelopment to the maximum of DdevelopmentðiÞ
  and
Daging to themaximumof DagingðjÞ
 , the inclusion ratio change index of
development (Idevelopment) and aging (Iaging) can be calculated as
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Idevelopment¼Ddevelopment/K and Iaging¼Daging/K, respectively, where
K¼ maxðmaxðIRnewbornÞ; IRyoung;maxðIRoldÞÞ. For DS2, the values of
seven DdevelopmentðiÞ and four DagingðjÞ terms were calculated, and
Ddevelopment and D

eging were selected as the second maximum absolute
value term. This was done to minimize the influence of outlier
inclusion ratio values. The inclusion ratio change indices, Idevelopment
and Ieging, were calculated as K¼ maxðfðIRnewbornÞ; IRyoung;fðIRoldÞÞ,
where f(K) denotes the second maximum value. Of the 1484 age-
related segments identified based on the whole-lifespan analysis of
splicing variation in DS1 and DS2, 853 segments showed splicing
changes in both development and aging and had consistent inclusion
ratio change direction in the two data sets, i.e.,
Idevelopment;ds1Idevelopment;ds24 0 and Iaging;ds1Iaging;ds24 0. Only these
segments were used in the analyses of developmental and aging
splicing changes.
The fraction of splicing changes that take place in development was
calculated as Idevelopment
 / Idevelopment
 þ Iaging
  . Among 1484 age-
related segments significant in both data sets, the mean values for
fraction of splicing changes taking place in development (± 1 s.d.)
were 0.676±0.195, 0.640±0.185, and 0.749±0.161 for DS1/PFC,
DS1/CBC, and DS2/PFC, respectively.
‘Down–up’ expression pattern analysis
The list of 12 447 genes expressed in the human PFC, as well as 7071
genes showing significant age-related expression changes in the PFC,
was obtained from (Liu et al, 2012). To identify genes following the
‘down–up’ expression pattern, we fit a quadratic curve to the
expression data of each of 6690 genes. The age of the samples was
counted starting from conception and log2-transformed. Overall, 2247
genes were classified as ‘down–up’ expressed genes.
Conservation analysis
PhastCons scores based on 10 primate species (Siepel et al, 2005) were
used to estimate segment conservation. Conservation of a given
segment was calculated as an average conservation of nucleotides
within this segment.
Rhesus macaque splicing variation analysis
To assess splicing in the rhesus macaque, boundaries of all segments
from 721 genes, containing 1484 of the age-related segments identified
in the human time series, weremapped to the rhesus genome using the
liftOver (Hinrichs et al, 2006) tool. Under the requirement that all the
segments in a gene should be mapped to the rhesus macaque genome
uniquely, 296 genes containing 538 age-related segmentsweremapped
unambiguously. Next, sequence reads from each of the 15 rhesus
samples (Supplementary Table S7) were aligned to the rhesus genome
byTophat, using the junction information of these 296 genes. Inclusion
ratios in the rhesus macaque data were calculated as described above.
Among the 538 age-related segments, 496 were covered by at least five
sequence reads in all rhesusmacaque samples, and by at least one read
crossing the tested splicing junction in at least one rhesus macaque
sample. These segments were used to confirm the splicing pattern
found in humans. Further, using the same criteria as for human DS2,
290 of the 496 segments showed significant age-related splicing
changes in the rhesus macaque time series data. For comparison
between the human and the rhesus macaque time series, the age of
rhesus macaque samples was adjusted to the human age based on the
maximal lifespan duration difference between the species (120 years
for humans and 40 years for rhesus macaques). To calculate the inter-
species inclusion ratio correlations, the human inclusion ratios were
translated to corresponding rhesus ages by quadratic interpolation
under quartic root age axis.
Splicing patterns
To define patterns based on age-related splicing changes, we first
constructed dendrograms of segments with significant age-related
splicing changes identified in both data sets and with the defined
inclusion ratio in all samples (N¼ 1422). This was done by
hierarchical clustering, using (1–r) as the distance measure, where
r is the Pearson correlation between vectors containing the inclusion
ratios of segments from samples in both brain regions and both data
sets.We used the ‘complete’ method for hierarchical clustering and cut
the tree at a height determined by a manual examination of pattern
profiles and by observing pattern functional properties at different
levels (h¼ 1.5). This procedure yielded eight patterns with strong
within-group correlations.
Functional enrichment analysis
The KEGG pathway annotation (Kanehisa et al, 2010) and the Gene
Ontology (GO) annotation (Ashburner et al, 2000) for humans were
downloaded from the KEGG (http://www.genome.jp/kegg/) and
Ensembl (version 56) databases, respectively. We used the GO ‘term’
and ‘graph path’ tables, downloaded from the GO database (http://
archive.geneontology.org/latest-termdb/), to associate each GO term
with higher level terms. To identify over-represented KEGG pathways
or GO terms, we used the Fisher’s exact test and adjusted P-values for
multiple testing by the Benjamini–Hochberg correction. Only path-
ways/terms containingX3 genes were tested.
Enrichment analysis of SFBMs
Sequences of 29 SFBMs were obtained from http://sfmap.technion.a-
c.il and another 7 SFBMwere collected fromprevious studies (Faustino
and Cooper, 2005; Galarneau and Richard, 2005; Sanford et al, 2009;
Bolognani et al, 2010) (Supplementary Table S11). These 36 SFBMs
corresponded to 25 SFs. To search for occurrence of these SFBM in the
vicinity of splicing sites, the boundary regions for each segment were
identified as 300bp upstream to 300bp downstream (Barash et al,
2010). Exact matches to each SFBM in each boundary region were
searched by a custom Perl script. For each SFBM, we used the Fisher’s
exact test to check whether there was an excess instances of this SFBM
in a splicing-pattern cluster, compared with all 1422 segments with
significant age-related splicing changes in both data sets. The enriched
SFBMs were defined as those satisfying the threshold Po0.05.
We further estimated the numbers of significantly enriched SFBM
expected by chance, by randomly sampling the same number of age-
related segments that were containedwithin the tested splicing-pattern
cluster, and repeating the enrichment test 1000 times. SFs showing
significant enrichment of SFBM based on this permutation test were
further tested for a correlation between their expression profiles and
their target segments’ inclusion ratios. To obtain a better resolution of
the temporal expression profiles of SFs, we used published Affymetrix
gene array data collected in the PFC and CBC of 23 human individuals
(Liu et al, 2012) with an age distribution matching that of DS1. To
calculate the correlation between the segments’ inclusion ratio profiles
and the SFs’ expression profiles across lifespan, we interpolated the
segment inclusion ratio values and the SF expression values from the
fitted spline curves at 15 equally distributed time points along the age
range. The SF-target segment inclusion ratio correlations were
compared with correlations between the same SF and its age-related
target segments in the other patterns, using the one-sided Wilcoxon
test. The test was conducted in the CBC and PFC separately, and the
SFs with significant correlation in both regions were classified as
correlated SFs. The expected-by-chance numbers of correlated SFs
with enriched SFBMswere calculated by random sampling in the other
patterns of the same number of age-related segments that were
contained within the tested pattern, and repeating the one-sided
Wilcoxon test 1000 times.
Identification of brain region-specific genes
To identify genes expressed differently between the two brain regions,
we quantified gene expression levels using counts of reads mapped
into constitutive and coding sections of a gene. These numbers and the
total numbers of mapped reads were tested using the binomial
regression performed as described above (Identification of splicing
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changes). Geneswith a significant (qo0.01) term responsible for brain
region differences were considered as brain-region specific. Of these,
genes with greater mean expression in PFC than in CBCwere classified
as PFC-specific and the remaining genes, as CBC-specific.
Multidimensional scaling analysis
Multidimensional Scaling to two dimensions was performed by the
isoMDS function from the MASS package in R. Inclusion ratios of each
segment in each data set and each brain region were normalized to
mean¼ 0 and s.d.¼ 1 before analysis. 1Pearson correlation coeffi-
cient was used as a distance function.
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (www.nature.com/msb).
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